Although the development of the new coronavirus vaccines is advancing at an incredible speed, medical professionals in R & D jobs have also been dedicating their focus to discovering medicines and treatments to administer to those who have already been infected with the virus.
Berlin, Germany -- (SBWIRE) -- 01/25/2021 -- Although the development of the new coronavirus vaccines is advancing at an incredible speed, medical professionals in R & D jobs have also been dedicating their focus to discovering medicines and treatments to administer to those who have already been infected with the virus. According to the German Association of Researched-based Pharmaceutical Companies (vfa), the majority of research has been focused on medicines that have already been approved or are in the late stages of development; for the treatment of other illnesses to provide a more rapid integration into a proposed treatment plan for a coronavirus patient. It's not solely a question of whether or not the drugs are successful in fighting COVID-19, but more specifically, at what stage of the disease would they be more effective in preventing the escalation of the disease to a critical stage in which the patient would require intensive care.
Founded in 2012, EPM Scientific is proud to be the leading specialist recruiter for a multitude of specialist life sciences sectors. From medical engineering to pharmacovigilance, R & D jobs, medical communications careers, regulatory, legal, and compliance and biometrics jobs, the organisation offers permanent, contract and multi-hire recruitment solutions across the life sciences industry. R & D professionals are needed throughout Germany, from Baden-Württemberg, Berlin, Munich and, more. EPM Scientific has over 750 dedicated consultants located in 12 offices internationally. The recruiting specialists at the firm undergo periodic training in best-in-class recruitment technology to ensure that candidates and clients receive optimal results. As part of the Phaidon Group, EPM Scientific's influence, stretches over 60 countries worldwide and is the chosen life science recruitment agency partner of a plethora of world-leading companies. The cooperation works with a variety of different companies from agile start-ups to global corporate giants to allow their candidates a wide range of choices when it comes to choosing a working culture that suits them best. The diligent professionals at EPM Scientific are committed to helping applicants through tailored support from source to hiring at every step of the recruiting process.
The firm adopts a recruitment beyond borders outlook whereby they endeavour to provide an internationally comprehensive service to ensure that talented professionals are able to explore opportunities throughout the world. At present, EPM Scientific have a great variety of roles available throughout Germany. Vacancies include, Translational Development Lead, Diagnostic Account Manager, Clinical Operations Manager, Medical Manager, Medical Directors and many more.
"Like many sectors, 2020 marked a defining moment for recruitment. Challenged by uncertainty, but unwavering in our commitment to our clients, we enter 2021 with a sense of duty to clients and candidates", commented Luis Rolim, Global Marketing Director at EPM Scientific. He went onto say, "as we reflect on the challenges of virtually securing and retaining talent, we're inspired by a team who have demonstrated a remarkable ability to adapt and continue to help all our clients secure top talent on a global scale."
To find out more information about life sciences recruitment in Germany visit
https://www.epmscientific.de/disciplines/safety-pharmacovigilance.
For any media enquiries please contact Gary Elliott at Iconic Digital – 020 7100 0726.
For all other enquiries please contact EPM Scientific DE: +49 30 72 62 11 444.
For more information about EPM Scientific DE services, please go to https://www.epmscientific.de.
About EPM Scientific DE
EPM Scientific DE partners with organisations across the fast expanding pharmacovigilance sector. The firm's 750+ employees support growth and development among enterprises where innovation and insight will be crucial to both current and future generations.